Skip to main content
Close
Home
Presented by
  • MDedge Neurology
Home
Full Menu Full Menu
  • Clinical Topics
  • Conference Coverage
  • Literature Review
  • MD-IQ
  • Clinical Edge Journal Scan

Expert Perspectives

September 1, 2023

Diversity in Multiple Sclerosis Care: How the Field of Underrepresented Minorities Has Evolved, and Where We Still See Areas for Improvement

September 1, 2023
Sylvia Klineova, MD
Sylvia Klineova, MD
September 1, 2023
ICYMI Multiple Sclerosis
April 21, 2023

Raising Awareness for Managing Disease-Modifying Therapies in Aging Persons With Multiple Sclerosis

April 21, 2023
Bianca Weinstock-Guttman, MD
Bianca Weinstock-Guttman, MD
April 21, 2023
ICYMI Multiple Sclerosis
February 10, 2023

Anti-CD20 Monoclonal Antibodies for Treating Multiple Sclerosis

February 10, 2023
Vijayshree Yadav, MD, MCR, FANA, FAAN
Vijayshree Yadav, MD, MCR, FANA, FAAN
February 10, 2023
ICYMI Multiple Sclerosis
January 25, 2023

Despite ongoing challenges, experts are optimistic about the future of MS therapy

January 25, 2023
Frieda Wiley
Frieda Wiley
January 25, 2023
ICYMI Multiple Sclerosis
Read More

Clinical Edge Journal Scan

May 27, 2022

Commentary: COVID-19 Treatment and Disease-Modifying Therapies in MS, June 2022

May 27, 2022
Mark Gudesblatt, MD
Mark Gudesblatt, MD
May 27, 2022
ICYMI Multiple Sclerosis
May 18, 2022

Multiple sclerosis type and female sex predict worsening lower urinary tract symptoms

May 18, 2022
May 18, 2022
ICYMI Multiple Sclerosis
May 18, 2022

Multiple sclerosis: Reduced humoral response contributes to breakthrough SARS-CoV-2 infection in patients on DMTs

May 18, 2022
May 18, 2022
ICYMI Multiple Sclerosis
May 18, 2022

T-cell response after third SARS-CoV-2 vaccination in patients with MS on ocrelizumab

May 18, 2022
May 18, 2022
ICYMI Multiple Sclerosis
Read More

MD-IQ

Fatigue in Multiple Sclerosis

Multiple Sclerosis and Visual Dysfunction

Multiple Sclerosis Subtypes

Multiple Sclerosis Risk Factors

More

Clinical Topics

January 25, 2023

Despite ongoing challenges, experts are optimistic about the future of MS therapy

January 25, 2023
Frieda Wiley
Frieda Wiley
January 25, 2023
ICYMI Multiple Sclerosis
August 30, 2022

Ublituximab bests teriflunomide in head-to-head clinical trials

August 30, 2022
Kate Johnson
Kate Johnson
August 30, 2022
ICYMI Multiple Sclerosis
June 22, 2022

COVID vaccination in DMT-treated MS patients: New data

June 22, 2022
Nancy A. Melville
Nancy A. Melville
June 22, 2022
CMSC: Consortium of Multiple Sclerosis Centers
ICYMI Multiple Sclerosis
June 3, 2022

B-cell level may affect COVID booster efficacy in MS

June 3, 2022
Kelli Whitlock Burton
Kelli Whitlock Burton
June 3, 2022
ICYMI Multiple Sclerosis
Read More

Literature Review

June 2, 2023

Stem cell transplants are more effective than some MS therapies

June 2, 2023
Jim Kling
Jim Kling
June 2, 2023
ICYMI Multiple Sclerosis
February 1, 2023

Biosimilar equal to natalizumab for relapsing remitting MS

February 1, 2023
Pauline Anderson
Pauline Anderson
February 1, 2023
ICYMI Multiple Sclerosis
January 3, 2023

Stem cell transplant superior to DMTs for secondary progressive MS

January 3, 2023
Kelli Whitlock Burton
Kelli Whitlock Burton
January 3, 2023
ICYMI Multiple Sclerosis
December 21, 2022

Four-gene signature linked to increased PML risk

December 21, 2022
Neil Osterweil
Neil Osterweil
December 21, 2022
ICYMI Multiple Sclerosis
December 5, 2022

High drug costs exclude most neurology patients from cutting-edge treatment

December 5, 2022
Megan Brooks
Megan Brooks
December 5, 2022
ICYMI Multiple Sclerosis
Read More

Conference Coverage

October 26, 2023

Subcutaneous ocrelizumab, ofatumumab ‘reassuring’ in MS

October 26, 2023
Liam Davenport
Liam Davenport
October 26, 2023
ICYMI Multiple Sclerosis
October 25, 2023

‘Frame running’ may help boost physical activity in MS

October 25, 2023
Liam Davenport
Liam Davenport
October 25, 2023
ECTRIMS: European Committee for Treatment and Research in Multiple Sclerosis
ICYMI Multiple Sclerosis
October 23, 2023

MS, DMTs, and pregnancy: Beware of over-caution regarding treatment

October 23, 2023
Randy Dotinga
Randy Dotinga
October 23, 2023
ECTRIMS: European Committee for Treatment and Research in Multiple Sclerosis
ICYMI Multiple Sclerosis
October 23, 2023

Wearable devices show promise in monitoring multiple sclerosis

October 23, 2023
Liam Davenport
Liam Davenport
October 23, 2023
ECTRIMS: European Committee for Treatment and Research in Multiple Sclerosis
ICYMI Multiple Sclerosis
October 20, 2023

NMO: Study says double diagnoses with MS are common

October 20, 2023
Randy Dotinga
Randy Dotinga
October 20, 2023
ECTRIMS: European Committee for Treatment and Research in Multiple Sclerosis
ICYMI Multiple Sclerosis
October 20, 2023

EBV and MS: Just how deep is the link?

October 20, 2023
Randy Dotinga
Randy Dotinga
October 20, 2023
ECTRIMS: European Committee for Treatment and Research in Multiple Sclerosis
ICYMI Multiple Sclerosis
October 18, 2023

Stem cell transplants in early MS: Who benefits most?

October 18, 2023
Randy Dotinga
Randy Dotinga
October 18, 2023
ECTRIMS: European Committee for Treatment and Research in Multiple Sclerosis
ICYMI Multiple Sclerosis
October 18, 2023

MS-tailored weight loss program achieves meaningful results

October 18, 2023
Liam Davenport
Liam Davenport
October 18, 2023
ECTRIMS: European Committee for Treatment and Research in Multiple Sclerosis
ICYMI Multiple Sclerosis
Read More

This Publication

  • MDedge Neurology
  • Clinical Neurology News
  • MD-IQ

Top Sections

  • Clinical Topics & News
  • Conference Coverage
  • Literature Monitor
  • Literature Review

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Menu Presented by
Menu Close
  • Clinical Topics
  • Conference Coverage
  • Expert Perspectives
  • Literature Review
  • MD-IQ
  • Clinical Edge Journal Scan

More

  • MDedge Neurology